Growing Demand For Microneedle Drug Delivery Systems Driven By Vaccine Research: Key Factor Driving The Growth In The Microneedle Drug Delivery Systems Market

The Microneedle Drug Delivery Systems Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Microneedle Drug Delivery Systems Market Size During the Forecast Period?
The market for microneedle drug delivery systems has experienced fast-paced expansion in the recent past. The market value is predicted to increase from $5.01 billion in 2024 to $5.9 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. The rise during the historic period is due to factors such as painless drug administration, improved patient adherence, the management of chronic illnesses, applications in cosmetics and aesthetics, and vaccine distribution.

Significant growth is expected in the microneedle drug delivery systems market in upcoming years, with projections indicating a rise to $11.44 billion by 2029 and a compound annual growth rate (CAGR) of 18.0%. The predicted rise in the market for this forecast period is associated with factors such as the use in cosmetic and aesthetic applications, emerging therapies, usage among the pediatric and geriatric population, global health initiatives, and point-of-care testing. The major trends steering this growth during the forecast period include the development of smart microneedles, progress in material science, strides in wearable technology, use of biodegradable materials, and continuous glucose monitoring.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5338

What Are the High-Growth Segments in the Microneedle Drug Delivery Systems Market?
The microneedle drug delivery systems market covered in this report is segmented -

1) By Technology: Hollow, Porous, Solid, Other Technologies
2) By Application: Drug Delivery, Vaccine Delivery, Other Applications
3) By End-User: Diagnostics Laboratories, Life Sciences, Research Laboratories, Hospitals, Ambulatory Surgical Centers, Other End-Users

Subsegments:
1) By Hollow: Solid Hollow Microneedles, Coated Hollow Microneedles
2) By Porous: Porous Silicon Microneedles, Hydrogel-Based Porous Microneedles
3) By Solid: Solid Microneedles For Vaccination, Solid Microneedles For Drug Delivery
4) By Other Technologies: Dissolving Microneedles, Biodegradable Microneedles, Micro-Infusion Systems

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5338&type=smp

What Key Drivers Are Expected to Influence Future Microneedle Drug Delivery Systems Market Growth?
The growth of the microneedle drug delivery systems market is projected to be fueled by the heightened research activity and increasing demand related to the vaccination procedure. Microneedles are perceived by researchers as an alternative method of vaccine administration that is virtually painless for the recipient. Initial development of microneedle patches vaccine was tailored towards flu and measles, but the technology is now being applied widely for COVID-19 vaccination as well. For example, records from the Office for National Statistics, a government agency in the UK, indicate that in April 2024, the British government's net spending on research and development (R&D), not taking into account contributions to the EU R&D budget, elevated to $17.01 billion (£15.5 billion) in 2022, up from $15.37 billion (£14.0 billion) in 2021, which denotes a 10.5% increase. When contributions to the EU R&D budget and knowledge transfer operations are factored in, the total net R&D expenditure for 2022 tallied up to $18.006 billion (£16.4 billion), signifying an 8.9% hike from $16.46 billion (£15.0 billion) the previous year. As a result, the amplified research effort and demand associated with the vaccination procedure are catalyzing the momentum of the microneedle drug delivery systems market.

Which Companies Hold the Largest Share Across Different Microneedle Drug Delivery Systems Market Segments?
Major companies operating in the microneedle drug delivery systems market include 3M Company, Zosano Pharma Corporation, Becton-Dickinson Technologies, Nanopass Technologies, Corium Inc., Valeritas Inc., Microdermics, TheraJect Inc., LTS Lohmann Therapie-Systeme AG, BioSerenTach (BT), Sorrento Therapeutics, Debiotech, Raphas Co. Ltd., QuadMedicine, Snvia Co. Ltd., NanoBiosciences LLC, AdminMed nanoBioSciences LLC, Nitto Denko Corporation, MyLife Technologies, Innoture Medical Technology Limited, Phillips-Medisize Corporation, Stemedica Cell Technologies Inc., Candela Corporation, Dermaroller GmbH, Micropoint Technologies, Vaxess Technologies, Micron Biomedical Inc., Kindeva Drug Delivery, Gurnet Point Capital, Moonlight Therapeutics Inc., Cutanos, Kimberly-Clark Corp., Clearside BioMedical Inc.

What Trends Are Driving Growth in The Microneedle Drug Delivery Systems Market?
Key companies in the microneedle drug delivery market are concentrating on product innovation, like radiofrequency microneedle systems, to improve customer services. A radiofrequency microneedle system is a minimal invasive method that merges microneedles with radiofrequency energy, improving drug delivery and prompting collagen creation in the skin for medicinal and aesthetic purposes. For example, Candela, a medical aesthetic device firm based in the US, introduced the Profound Matrix system in February 2023. This versatile system includes the Sublime, Sublative RF, and the pioneering Matrix Pro applicators. Both the Sublime and Sublative RF use bipolar radiofrequency (RF) technology to ameliorate fine lines and wrinkles, while the Matrix Pro applicator concentrates on rekindling and promoting collagen generation. It includes a series of slim microneedles that deliver short-pulse RF energy to the skin, enhancing patient comfort, diminishing downtime, and boosting the overall outcomes.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/microneedle-drug-delivery-systems-global-market-report

What Are the Emerging Geographies for The Microneedle Drug Delivery Systems Market Growth?
North America was the largest region in the microneedle drug delivery systems market in 2024. Europe was the second-largest region in the microneedle drug delivery systems market analysis. The regions covered in the microneedle drug delivery systems market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Microneedle Drug Delivery Systems Market?
2. What is the CAGR expected in the Microneedle Drug Delivery Systems Market?
3. What Are the Key Innovations Transforming the Microneedle Drug Delivery Systems Industry?
4. Which Region Is Leading the Microneedle Drug Delivery Systems Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.